This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Florence Lai, MD; Roger S. Williams, MD

Arch Neurol. 1989;46(8):849-853.

Abstract
• Ninety-six individuals with Down syndrome over age 35 years were evaluated and followed up for evidence of nontreatable dementia. Dementia was judged to be present when a functional decline occurred in areas such as orientation, memory, verbal and motor skills, and self-care abilities. Forty-nine patients with Down syndrome fit this criterion, with an average onset of dementia at 54.2 ± 6.1 years. The prevalence of dementia in the institutionalized Down syndrome population of our study (n = 53) was 8% (2/25 patients) between 35 and 49 years, 55% (11/20 patients) between 50 and 59 years, and 75% (6/8 patients) of those over 60 years old. Of note, 41 (84%) demented individuals with Down syndrome developed seizures. Ten (20%) had parkinsonian features. Adequately treated hypothyroidism was present in 27 (59%) of 46 demented patients with Down syndrome tested. The average duration of dementia in the 23 patients who died was 4.6 ± 3.2 years. Computed tomographic scans in 43 patients all showed brain tissue loss, most pronounced in the temporal lobes. Brains from 12 autopsied cases showed large numbers of plaques and tangles in the same locations as in persons with Alzheimer disease.

Author Affiliations
From the Eunice Kennedy Shriver Center, Waltham, Mass; Massachusetts General Hospital and Harvard Medical School, Boston, Mass. Dr Williams is now with the Billings (Mont) Clinic.

Footnotes
Accepted for publication February 16, 1989.

Read in part before the 39th Annual Meeting of the American Academy of Neurology, New York, NY, April 9, 1987.

Reprint requests to Eunice Kennedy Shriver Center, 200 Trapelo Rd, Waltham, MA 02254 (Dr Lai).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Down syndrome--recent progress and future prospects
Wiseman et al.
Hum Mol Genet 2009;18:R75-R83.
ABSTRACT | FULL TEXT  

Epilepsy and Cognitive Impairments in Alzheimer Disease
Palop and Mucke
Arch Neurol 2009;66:435-440.
ABSTRACT | FULL TEXT  

Elevated Plasma beta-Amyloid Peptide Abeta42 Levels, Incident Dementia, and Mortality in Down Syndrome
Schupf et al.
Arch Neurol 2007;64:1007-1013.
ABSTRACT | FULL TEXT  

The subjective experience of individuals with Down syndrome living with dementia
Lloyd et al.
Dementia 2007;6:63-88.
ABSTRACT  

Phenotype associated with APP duplication in five families
Cabrejo et al.
Brain 2006;129:2966-2976.
ABSTRACT | FULL TEXT  

Alzheimer's dementia in persons with Down's syndrome: Predicting time spent on day-to-day caregiving
McCarron et al.
Dementia 2005;4:521-538.
ABSTRACT  

Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry
Teipel et al.
Brain 2004;127:811-824.
ABSTRACT | FULL TEXT  

Temporal cortex hypermetabolism in Down syndrome prior to the onset of dementia
Haier et al.
Neurology 2003;61:1673-1679.
ABSTRACT | FULL TEXT  

Relation of Corpus Callosum and Hippocampal Size to Age in Nondemented Adults With Down's Syndrome
Teipel et al.
Am. J. Psychiatry 2003;160:1870-1878.
ABSTRACT | FULL TEXT  

Why Wait for Dementia?
Watchman
J Intellect Disabil 2003;7:221-230.
ABSTRACT  

Screening for Dementia in Primary Care: A Summary of the Evidence for the U.S. Preventive Services Task Force
Boustani et al.
ANN INTERN MED 2003;138:927-937.
ABSTRACT | FULL TEXT  

Adverse effects of phenytoin given for late-onset seizures in adults with Down syndrome
Tsiouris et al.
Neurology 2002;59:779-780.
FULL TEXT  

Genetic and host factors for dementia in Down's syndrome
SCHUPF and Sergievsky
Br. J. Psychiatry 2002;180:405-410.
ABSTRACT | FULL TEXT  

APOE {epsilon}4 influences the manifestation of Alzheimer's disease in adults with Down's syndrome
DEB et al.
Br. J. Psychiatry 2000;176:468-472.
ABSTRACT | FULL TEXT  

Temporal Accrual of Complement Proteins in Amyloid Plaques in Down’s Syndrome with Alzheimer’s Disease
Stoltzner et al.
Am. J. Pathol. 2000;156:489-499.
ABSTRACT | FULL TEXT  

High Brain myo-Inositol Levels in the Predementia Phase of Alzheimer’s Disease in Adults With Down’s Syndrome: A 1H MRS Study
Huang et al.
Am. J. Psychiatry 1999;156:1879-1886.
ABSTRACT | FULL TEXT  

APOE genotype and gender effects on Alzheimer disease in 100 adults with Down syndrome
Lai et al.
Neurology 1999;53:331-331.
ABSTRACT | FULL TEXT  

MRI Volumes of the Hippocampus and Amygdala in Adults With Down's Syndrome With and Without Dementia
Aylward et al.
Am. J. Psychiatry 1999;156:564-568.
ABSTRACT | FULL TEXT  

The Role of Magnetic Resonance Imaging in the Diagnosis of Alzheimer Disease in Adults With Down Syndrome
Prasher et al.
Arch Neurol 1996;53:1310-1313.
ABSTRACT  

Neuropathological Changes in Down's Syndrome Hippocampal Formation: Effect of Age and Apolipoprotein E Genotype
Hyman et al.
Arch Neurol 1995;52:373-378.
ABSTRACT  

Age-Related Distribution of Neuropathologic Changes in the Cerebral Cortex of Patients With Down's Syndrome: Quantitative Regional Analysis and Comparison With Alzheimer's Disease
Hof et al.
Arch Neurol 1995;52:379-391.
ABSTRACT